cefmatilen has been researched along with Bacteremia* in 1 studies
1 other study(ies) available for cefmatilen and Bacteremia
Article | Year |
---|---|
In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin.
S-1090, a new oral cephalosporin, was active against selected gram-negative bacteria and methicillin-susceptible clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus warneri, against which it had excellent activity. S-1090 was the most active compound against Streptococcus pyogenes and Streptococcus agalactiae among the agents compared. The in vivo efficacy of S-1090 against systemic and urinary and respiratory tract infections caused by gram-positive and -negative bacteria was superior to that expected from the in vitro and in vivo activities of the agents against which it was compared. Topics: Animals; Bacteremia; Bacteria; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1995 |